JACOB PULIYEL VS UNION OF INDIA WRIT PETITION (CIVIL) NO. 607 OF 2021:

DATE: 02/05/2022

BENCH: Justice L. Nageswara Rao and Justice Bhushan Ramkrishna Gavai

FACTS:

Mr. Jacob Puliyel, a former member of the National Technical Advisory Group on Immunization (NTAGI), filed a Public Interest Litigation (PIL) before the Honorable Supreme Court of India, challenging certain aspects of India's vaccination policies and regulatory procedures. In his petition, Mr. Puliyel raised concerns about the mandatory nature of COVID-19 vaccination, arguing that such a requirement is unfair, unconstitutional, and a violation of fundamental rights under Article 21 of the Indian Constitution, which guarantees the right to life and personal liberty.

Mr. Puliyel emphasized the need for greater transparency regarding vaccine trials, particularly for Covishield and Covaxin. He demanded that the government disclose all relevant data associated with the clinical trials of these vaccines to ensure public access to critical information. He also expressed concerns over the emergency approval process for these vaccines, questioning the adequacy of regulatory scrutiny and the robustness of safety evaluations.

Furthermore, Mr. Puliyel highlighted potential shortcomings in the regulatory framework concerning Adverse Events Following Immunization (AEFI). He argued that inadequate assessment and lack of detailed data disclosure regarding adverse events posed a significant risk to public health and safety. He maintained that withholding such information violated constitutional principles and undermined public trust in the vaccination process. Through his petition, Mr. Puliyel urged the Supreme Court to direct the government to make all vaccine trial data publicly accessible and to reconsider the legality and fairness of mandatory vaccination policies.

ISSUES:

The key issues raised in the case include whether mandatory vaccination violates Article 21 of the Indian Constitution, which safeguards the right to life and personal liberty. Additionally, the case questions whether segregated clinical trial data for vaccines like Covishield and Covaxin should be made publicly accessible to ensure transparency. Concerns were also raised regarding the alleged improper collection and reporting of data by the Adverse Events Following Immunization (AEFI) system. Lastly, the petition challenges the safety of COVID-19 vaccines, particularly for children, urging a thorough evaluation of their potential risks and benefits.

JUDGEMENT WITH REASONING:

The Supreme Court ruled that while the government can strongly recommend vaccination in the interest of public health, it cannot impose mandatory vaccination on individuals, as this would violate the fundamental right to personal autonomy under Article 21 of the Indian Constitution. The Court also directed the government to disclose vaccine trial data, stating that transparency is crucial to maintain public trust. Additionally, the Court emphasized the need for proper reporting and investigation of Adverse Events Following Immunization (AEFIs) to ensure accountability. The judgment upheld the importance of informed consent and recognized individual choice in vaccination decisions, particularly for children.

The Supreme Court's reasoning centred on the fundamental right to personal autonomy guaranteed under Article 21 of the Indian Constitution. The Court acknowledged that while vaccination is an effective tool to curb the spread of infectious diseases, mandating it without individual consent would infringe upon the right to bodily integrity and informed choice. The Court emphasized that individuals have the right to make medical decisions for themselves and their children unless a clear legal mandate with justifiable grounds exists. It also observed that public health policies must balance societal welfare with individual rights, and the absence of a statutory framework enforcing mandatory vaccination further supported the view that citizens cannot be compelled to vaccinate.

Regarding the demand for vaccine trial data, the Court highlighted the need for transparency in public health initiatives to build public trust. It ruled that comprehensive data on clinical trials, vaccine efficacy, and adverse effects must be accessible to the public while safeguarding sensitive information. The Court also underscored the importance of proper documentation and investigation of Adverse Events Following Immunization (AEFIs) to ensure accountability and address safety concerns. By reinforcing the principles of informed consent, transparency, and public accountability, the Court ensured that citizens' rights were protected without compromising public health objectives.

ANALYSIS:

The Supreme Court's decision reflects a careful balance between individual rights and public health objectives. By affirming that mandatory vaccination is unconstitutional under Article 21, the Court reinforced the principle of bodily autonomy and informed consent. This ruling underscores the importance of individual choice in medical decisions, acknowledging that while vaccination is a vital public health measure, compelling individuals to receive it without their consent violates fundamental rights. The Court’s emphasis on the absence of statutory backing for mandatory vaccination further highlights the need for legal clarity in implementing public health policies. By distinguishing between recommending vaccination and enforcing it through coercion, the Court safeguarded citizens’ rights while still recognizing the broader benefits of immunization.

In addressing concerns about transparency, the Court's directive to disclose clinical trial data reflects its commitment to accountability in public health governance. By ordering the government to make vaccine-related data publicly accessible, the Court sought to ensure that citizens can make informed choices based on reliable information. This decision also strengthens public trust in vaccination efforts, as transparency can help dispel misinformation and build confidence in the safety and efficacy of vaccines. Additionally, the Court's emphasis on proper documentation and investigation of Adverse Events Following Immunization (AEFIs) underscores the importance of a robust regulatory framework to track, analyze, and respond to vaccine-related concerns. This approach ultimately reinforces both individual rights and public health safety, ensuring that citizens are empowered with accurate information while promoting responsible immunization practices.